haleon plc glp-1 receptor agonist medications Advil Maker's CEO Aims to Play in Weight-Loss Market From Sidelines GLP-1 Focus Central To Haleon's
Description
We searched for approved generic competitors in the Orange Book to determine if the expected duration of protection for brand-name products had been cut short by early generic competition, and we used the FDAs Paragraph IV Certifications List (updated through the end of 2022) to identify patent challenges on brand-name products in the cohort

They produce significant weight loss but come with gastrointestinal side effects, muscle and bone density loss, emerging concerns around dampened desire and libido, high cost, and weight regain when discontinued

[DOI] [PMC free article] [PubMed] [Google Scholar] 6

This drug, which got the green light from the FDA on April 1, stands out because its a tablet: a huge attraction for the millions of people who struggle with needles and injections

Some of GLP-1s primary roles include: Controlling appetite

Since gastric distension (both of the proximal and distal stomach) can lead to reduced food/energy intake (64, 65), the question arises as to whether the slowing of gastric emptying, via increased gastric distension, contributes to the regulation of appetite and energy intake
